Showing 2 posts by Mitchell P. Morinec.
In an effort to combat the COVID-19 pandemic President Donald Trump has invoked the Defense Production Act (“DPA”), specifically ordering General Motors (“GM”) to manufacture ventilators. Of course, GM does not normally produce ventilators. Just this week the President, threatening to invoke the DPA, reached an agreement with 3M Company as to where and to whom it would deliver its protective face masks. As the number of diagnosed cases and deaths increase in the United States, it is likely that other companies will be under executive orders to produce products outside their areas of expertise. The DPA is a powerful law that was written in the spirit of the industrial mobilization that the United States implemented during World War II and could very well help to carry us through this pandemic. But what will happen if one of GM’s ventilators contains a manufacturing defect? What if a drug or medical device company under executive orders produces a product that harms a patient, medical treater, or someone else? Can those companies be subject to liability? The answer lies in the interplay between the DPA and the Public Readiness and Emergency Preparedness (“PREP”) Act. More »
LIFE SCIENCES CLIENT ALERT: United States Supreme Court holds that the judge, not the jury, makes pre-emption determination in failure-to-warn pharmaceutical cases.
It is the role of the district judge—not the jury—to determine if the FDA would have approved a drug’s warning label that state law requires when deciding whether a failure-to-warn claim is pre-empted, the United States Supreme Court held on Monday. The unanimous decision provides clarity to the high court’s “clear evidence” standard it introduced over a decade ago in Wyeth v. Levine, and resolves a split between the circuit courts in how to apply the standard. More »
- Case Involving Field Manufacturer Highlights the Need to Preserve Error and Get a Written Ruling on Objections to Summary Judgment Evidence
- In Defense of Long-Term Care Facilities: Immunity, and What to do if There is Not Any
- Changes to Punitive Damages Coming to Missouri
- Retro-Fitting Reservations: The Re-Opening of Restaurants Amidst the COVID-19 Crisis
- Florida's Religious Re-Opening: Guidance For Faith Based Institutions To Mitigate Liability In Epidemic/Pandemic Events
- The Future of E-Cigarette Litigation: Is There One?
- Re-Opening States and Businesses and the Role OSHA May Play
- COVID-19 Pandemic Negligence Claims Update: Developing Legal Immunity for Health Care Professionals
- Michigan Governor Signs Executive Order Cutting Red Tape for Motor Carriers During the COVID-19 Pandemic
- Will Drug and Medical Device Manufacturers Combating COVID-19 be Subject to Tort Liability?
- Professional Liability
- Class Action
- Insurance Coverage
- Insurance & Reinsurance Litigation & Counseling
- Complex Commercial Litigation
- Cyber Risk & Liability
- Toxic Tort
- Professional Development
- Construction Litigation & Counseling
- Workers' Compensation
- Pharmaceutical & Medical Device Litigation
- Discrimination, Harassment & Hostile Workplace Claims
- Medical Negligence & Healthcare Liability
- Product Liability
- Social Media & Privacy
- Employment Litigation & Counseling